Aerovate Therapeutics (AVTE) Q2 2024 Earnings

13MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.83
-0.55
-0.28
0

Details

Expected EPS
-0.764567
Actual EPS
-0.83
Surprise EPS
-0.07
Surprise Percent
+8.56%

Description

Aerovate Therapeutics (AVTE) has reported earnings of -0.83 per share for Q2 2024.

0 Comments

Share your thoughts